Published in Lancet on March 10, 1984
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med (2009) 5.47
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine (2008) 1.61
Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am (2013) 1.40
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
The status of CMV as a human pathogen. Epidemiol Infect (1988) 1.17
Immune responses to isolated human cytomegalovirus envelope proteins. J Virol (1986) 1.09
Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J Virol (1998) 1.05
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies. Proc Natl Acad Sci U S A (2014) 0.99
Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol (2015) 0.92
Acquisition of cytomegalovirus infection: an update. Clin Microbiol Rev (1989) 0.91
Congenital cytomegalovirus infection. Br Med J (Clin Res Ed) (1987) 0.90
Human cytomegalovirus infection. Thorax (1989) 0.88
Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine. J Biomed Biotechnol (2011) 0.87
Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. J Clin Invest (2014) 0.86
Detection of cytomegalovirus antibody by enzyme immunoassay and lack of evidence for an effect resulting from strain heterogeneity. J Clin Microbiol (1986) 0.85
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. J Infect Dis (2016) 0.84
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease. Cell Mol Immunol (2014) 0.83
Cytomegalovirus infections in renal transplant recipients. Br Med J (Clin Res Ed) (1984) 0.82
Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92. J Virol (2014) 0.81
DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus. Hum Vaccin Immunother (2013) 0.78
Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo. Virus Genes (2017) 0.75
Stanley Plotkin: the bright spark of cytomegalovirus vaccines. Med Microbiol Immunol (2015) 0.75
Immunological aspects of the prevention of viral diseases. WHO Workshop. Bull World Health Organ (1987) 0.75
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog (2016) 0.75
Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers. J Virol (2016) 0.75
Ampicillin-resistant Haemophilus influenzae type B infection. JAMA (1974) 5.90
CCAAT-enhancer binding protein: a component of a differentiation switch. Science (1991) 5.61
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev (1989) 5.59
Field Evaluation of a Human Anthrax Vaccine. Am J Public Health Nations Health (1962) 5.44
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med (1974) 4.19
Micromethod system for identification of anaerobic bacteria. Appl Microbiol (1973) 4.18
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood (1992) 3.18
Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults. J Clin Microbiol (1979) 2.95
Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS (2001) 2.85
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
Necrotizing fasciitis. Chest (1996) 2.74
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
Varicella vaccine for healthy children. Lancet (1994) 2.64
The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther (1993) 2.52
Comparison of three anaerobic systems for the isolation of anaerobic bacteria from clinical specimens. Am J Clin Pathol (1973) 2.47
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med (1991) 2.42
Human cytomegalovirus stimulates host cell RNA synthesis. J Virol (1975) 2.41
A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood. Am J Epidemiol (1968) 2.36
Immunologically privileged sites. Adv Immunol (1977) 2.35
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science (1984) 2.34
Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg (2001) 2.27
Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25
Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol (1975) 2.21
Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells. J Immunol (1977) 2.21
Legionnaires' disease in non-Legionnaires. A report of five cases. Ann Intern Med (1978) 2.18
The management of bite wounds. N Engl J Med (1999) 2.16
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb Pathog (1987) 2.15
Clinical and cost-effectiveness of outpatient strategies for management of febrile infants. Pediatrics (1992) 2.12
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Clin Invest (1982) 2.02
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00
Candidate cytomegalovirus strain for human vaccination. Infect Immun (1975) 1.99
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis (1988) 1.97
Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics (1995) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis (1995) 1.92
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91
Minimal infective dose of attenuated poliovirus for man. Am J Public Health Nations Health (1967) 1.89
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis (1989) 1.89
Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr (1992) 1.87
Virus infection of endothelial cells. J Infect Dis (1981) 1.87
Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc Soc Exp Biol Med (1978) 1.78
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods (1983) 1.76
C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol (1996) 1.76
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children. JAMA (1999) 1.75
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes (1997) 1.75
C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1. Oncogene (2007) 1.75
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of age, treated as outpatients. Occult Bacteremia Study Group. J Pediatr (1995) 1.73
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol (1977) 1.73
Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol (1991) 1.73
Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol (1986) 1.72
Assessment of living renal donors with spiral CT. Radiology (1995) 1.71
Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. Br Med J (1965) 1.70
Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis (1990) 1.69
Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol (1998) 1.69
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis (1976) 1.68
Stimulation of macromolecular synethesis in guinea pig cells by human CMV. Proc Soc Exp Biol Med (1975) 1.67
A technique for management of multiple renal arteries after laparoscopic donor nephrectomy. Transplantation (1997) 1.67
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics (1982) 1.64
Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis (1999) 1.64
Human cell culture rabies vaccine. Antibody response in man. JAMA (1973) 1.63
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63
Vulvovaginitis in premenarcheal girls: clinical features and diagnostic evaluation. Pediatrics (1982) 1.62
Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis (1991) 1.62
In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol (1998) 1.59
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine (1991) 1.57
Nonproductive infection of guinea pig cells with human cytomegalovirus. J Virol (1973) 1.56
Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child (1966) 1.56
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol (1999) 1.56
A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion. Am J Epidemiol (1967) 1.56
Popliteal artery aneurysms: current management and outcome. J Vasc Surg (1994) 1.55
Incidence of bacteremia in infants and children with fever and petechiae. J Pediatr (1997) 1.51
Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med (1988) 1.51
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant (1998) 1.51
Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics (1990) 1.50
Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics (1985) 1.50
Rapid laboratory diagnosis of infections. Pediatr Infect Dis (1983) 1.49
The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol Cell Biol (1993) 1.48
In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med (1999) 1.46
Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med (1995) 1.46
Magnetic resonance angiography of peripheral runoff vessels. J Vasc Surg (1992) 1.45
Outbreak of cryptosporidiosis in a day-care center. Pediatrics (1986) 1.44